Expected Moves

Oct 28, 2026→Nov 10, 2026

Dec 15, 2026→Dec 30, 2026

Year-end strategic update detailing returns on the recent $33.1M quarterly CapEx and progress in the clinical biologics pipeline.

Mar 30, 2027→Apr 14, 2027

Full-year 2026 financials and management guidance for the upcoming fiscal year, serving as a reality check on the company's $4.79B market…

Apr 28, 2027→May 12, 2027

First quarter results setting the operational tone for 2027, with intense focus on operating cash flow and margin health.

Jun 20, 2027→Jul 5, 2027

Sector-wide volume-based procurement (VBP) and regional tender pricing updates affecting the biologics and blood products market.